Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19421185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females
Condition: Osteoporosis
Interventions: Drug: odanacatib;   Drug: Comparator: placebo to MK0822
2 Completed Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
Condition: Osteoporosis
Interventions: Drug: odanacatib;   Drug: Comparator: Placebo

Indicates status has not been verified in more than two years